Ventrolateral periaqueductal gray lesion attenuates nociception but does not change anxiety-like indices or fear-induced antinociception in mice

Behavioural Brain Research

Volumn 219, Issue 2, 2011, Pages 248-253

  Mendes Gomes, Joyce ^a,b   Amaral, Vanessa Cristiane Santana ^b   Nunes de Souza, Ricardo Luiz ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Antinociception; Anxiety; Different types of EPM; Fear; Formalin test; Mice; NMDA lesion; Ventrolateral periaqueductal gray

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ANXIETY; ARTICLE; AVERSION; BRAIN DAMAGE; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; FEAR; LOCOMOTION; MALE; MAZE TEST; MOUSE; NOCICEPTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; STIMULUS RESPONSE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; EXCITATORY AMINO ACID AGONISTS; FEAR; FORMALDEHYDE; MALE; MAZE LEARNING; MICE; N-METHYLASPARTATE; NOCICEPTORS; PAIN; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY;

EID: 79952702381     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.01.012     Document Type: Article

References (69)

1. Reynolds D.V. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 1969, 164:444-445.
2. Fields H.L., Basbaum A.I., Heinricher M.M. Central nervous system mechanisms of pain modulation. Wall and Melzack's textbook of pain 2006, 125-142. Elsevier, Churchill Livingstone. 5th ed. S.B. McMahom, M. Koltzenburg (Eds.).
3. Behbehani M.M. Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol 1995, 46:575-605.
4. Heinricher M.M., Tavares I., Leith J.L., Lumb B.M. Descending control of nociception: specificity, recruitment and plasticity. Brain Res Rev 2009, 60:214-225.
5. Bandler R., Shipley M.T. Columnar organization in midbrain periaqueductal gray: modules for emotional expression?. Trends Neurosci 1994, 17:379-389.
6. Carrive P. The periaqueductal gray and defensive behavior: functional representation and neuronal organization. Behav Brain Res 1993, 58:27-47.
7. Depaulis A., Keay K.A., Bandler R. Quiescence and hyporeactivity evoked by activation of cell bodies in the ventrolateral midbrain periaqueductal gray of the rat. Exp Brain Res 1994, 99:75-83.
8. Hilton S.M., Redfern W.S. A search for brainstem cell groups integrating the defence reaction in the rat. J Physiol 1986, 378:213-228.
9. Keay K.A., Bandler R. Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci Biobehav Rev 2001, 25:669-678.
10. Lovick T.A. Interactions between descending pathways from the dorsal and ventrolateral periaqueductal gray matter in the rat. The midbrain periaqueductal gray: functional, anatomical and neurochemical organization 1991, 101-120. Plenum Press, New York. A. Depaulis, R. Bandler (Eds.).
11. Morgan M.M. Differences in antinociception evoked from dorsal and ventral regions of the caudal and periaqueductal gray matter. The midbrain periaqueductal gray: functional, anatomical and neurochemical organization 1991, 139-150. Plenum Press, New York. A. Depaulis, R. Bandler (Eds.).
12. Depaulis A., Keay K.A., Bandler R. Longitudinal neuronal organization of defensive reactions in the midbrain periaqueductal gray region of the rat. Exp Brain Res 1992, 90:307-318.
13. Lovick T.A. Integrated activity of cardiovascular and pain regulatory systems: role in adaptative behavioral responses. Prog Neurobiol 1993, 40:631-644.
14. Bellgowan P.S., Helmstetter F.J. Neural systems for the expression of hypoalgesia during nonassociative fear. Behav Neurosci 1996, 110:727-736.
15. Fanselow M.S. The midbrain periaqueductal gray as a coordinator of action in response to fear and anxiety. The midbrain periaqueductal gray matter 1991, 1-8. Plenum Press, New York. A. Depaulis, R. Bandler (Eds.).
16. Harris J.A. Descending antinociceptive mechanisms in the brainstem: their role in the animal's defensive system. J Physiol Paris 1996, 90:15-25.
17. Siegfried B., Frischknecht H.R., Nunes-De-Souza R.L. An ethological model for the study of activation and interaction of pain, memory and defensive systems in the attacked mouse. Role of endogenous opioids. Neurosci Biobehav Rev 1990, 14:481-490.
18. Bolles R.C., Fanselow M.S. A perceptual-defensive-recuperative model of fear and pain. Behav Brain Sci 1980, 3:291-322.
19. Graeff F.G. Brain defense systems and anxiety. Handbook of anxiety 1990, vol.3:307-354. Elsevier, New York.
20. Graeff F.G. Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 2004, 28:239-259.
21. Carobrez A.P., Bertoglio L.J., Ethological temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 2005, 29:1193-1205.
22. Conceição I.M., Maiolini M., Mattia N., Vital M.A., Santos B.R., Smaili S., Frussa-Filho R. Anxiety-induced antinociception in the mouse. Braz J Med Biol Res 1992, 25:831-834.
23. Lee C., Rodgers R.J. Antinociceptive effects of plus-maze exposure: influence of opiate receptor manipulations. Psychopharmacology (Berlin) 1990, 102:507-513.
24. Stephens D.N., Meldrum B.S., Weidmann R., Schneider C., Grutzner M. Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity?. Psychopharmacology (Berlin) 1986, 90:166-169.
25. Taukulis H.K., Goggin C.E. Diazepam-stress interactions in the rat: effects on autoanalgesia and a plus-maze model of anxiety. Behav Neural Biol 1990, 53:205-216.
26. Mendes-Gomes J., Nunes-De-Souza R.L. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice. Brain Res 2005, 1047:97-104.
27. Mendes-Gomes J., Nunes-De-Souza R.L. Anxiolytic-like effects produced by bilateral lesion of the periaqueductal gray in mice: influence of concurrent nociceptive stimulation. Behav Brain Res 2009, 203:180-187.
28. Cornélio A.M., Nunes-De-Souza R.L. Open elevated plus maze-induced antinociception in rats: a non-opioid type of pain inhibition?. Physiol Behav 2009, 96:440-447.
29. Fanselow M.S., Landeira-Fernandez J., Decola J.P., Kim J.J. The immediate-shock deficit and postshock analgesia: implication for the relationship between the analgesic CR and UR. Anim Learn Behav 1994, 22:72-76.
30. Deacon R.M., Croucher A., Rawlins J.N.P. Hippocampal cytotoxic lesion effects on species-typical behaviors in mice. Behav Brain Res 2002, 132:203-213.
31. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, California. 2nd ed.
32. Abbott F.V., Franklin K.B.J., Westbrook R.F. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 1995, 60:91-102.
33. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brainstem stimulation in rats and cats. Pain 1977, 4:161-174.
34. McCall W.D., Tanner K.D., Levine J.D. Formalin induces biphasic activity in C-fibers in the rat. Neurosci Lett 1996, 208:45-48.
35. Bon K., Wilson S.G., Mogil J.S., Roberts W.J. Genetic evidence for the correlation of deep dorsal horn Fos protein immunoreactivity with tonic formalin pain behavior. J Pain 2002, 3:181-189.
36. Tjolsen A., Berge O.G., Hunskaar S., Rosland J.H., Hole K. The formalin test: an evaluation of the method. Pain 1992, 51:5-17.
37. Le Bars D., Gozariu M., Cadden S.W. Animal models of nociception. Pharmacol Rev 2001, 53:597-652.
38. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin) 1987, 92:180-185.
39. Sukikara M.H., Mota-Ortiz S.R., Baldo M.V., Felicio L.F., Canteras N.S. A role for the periaqueductal gray in switching adaptive behavioral responses. J Neurosci 2006, 26:2583-2589.
40. Heeb M.M., Yahr P. Cell-body lesions of the posteriodorsal preoptic nucleus or posteriodorsal medial amygdala, but not the parvicellular subparafascicular thalamus, disrupt mating in male gerbils. Physiol Behav 2000, 68:317-331.
41. Blanchard D.C., Williams G., Lee M.C., Blanchard R.J. Taming of wild Rattus novergicus by lesions of the mesencephalic central gray. Physiol Psychol 1981, 9:157-163.
42. Dielenberg R.A., Leman S., Carrive P. Effect of dorsal periaqueductal gray lesions on cardiovascular and behavioral responses to cat odor exposure in rats. Behav Brain Res 2004, 153:487-496.
43. Brandão M.L., Troncoso A.C., De Souza Silva M.A., Huston J.P. The relevance of neuronal substrates of defense in the midbrain tectum to anxiety and stress: empirical and conceptual considerations. Eur J Pharmacol 2003, 463:225-233.
44. Bandler R., Keay K.A., Floyd N., Price J. Central circuits mediating patterned autonomic activity during active vs. passive emotional coping. Brain Res Bull 2000, 53:95-104.
45. Vianna D.M., Brandão M.L. Anatomical connections of the periaqueductal gray: specific neural substrates for different kinds of fear. Braz J Med Biol Res 2003, 36:557-566.
46. Helmstetter F.J., Tershner S.A. Lesions of the periaqueductal gray and rostral ventromedial medulla disrupt antinociceptive but not cardiovascular aversive conditional responses. J Neurosci 1994, 14:7099-7108.
47. Vanegas H., Schaible H.G. Descending control of persistent pain: inhibitory or facilitatory?. Brain Res Rev 2004, 46:295-309.
48. Keay K.A., Bandler R. Distinct central representations of inescapable and escapable pain: observations and speculation. Exp Physiol 2002, 87:275-279.
49. Lumb B.M., Parry D.M., Semenenko F.M., McMullan S., Simpson D.A. C-nociceptor activation of hypothalamic neurones and the columnar organization of their projections to the periaqueductal grey in the rat. Exp Physiol 2002, 87:123-128.
50. Parry D.M., Semenenko F.M., Conley R.K., Lumb B.M. Noxious somatic inputs to hypothalamic-midbrain projection neurones: a comparison of the columnar organization of somatic and visceral inputs to the periaqueductal grey in the rat. Exp Physiol 2002, 87:117-122.
51. Rodella L., Rezzani R., Gioia M., Tredici G., Bianchi R. Expression of Fos immunoreactivity in the rat supraspinal regions following noxious visceral stimulation. Brain Res 1998, 47:357-366.
52. Morgan M.M., Carrive P. Activation of the ventrolateral periaqueductal gray reduces locomotion but not mean arterial pressure in awake, freely moving rats. Neuroscience 2001, 102:905-910.
53. Morgan M.M., Whitney P.K., Gold M.S. Immobility and flight associated with antinociception produced by activation of the ventral and lateral/dorsal regions of the rat periaqueductal gray. Brain Res 1998, 804:159-166.
54. Ito M. The cerebellum and neural control 1984, Raven Press, New York.
55. Cerminara N.L., Koutsikou S., Lumb B.M., Apps R. The periaqueductal grey modulates sensory input to the cerebellum: a role in coping behavior?. Eur J Neurosci 2009, 29:2197-2206.
56. De Luca-Vinhas M.C.Z., Macedo C.E., Brandão M.L. Pharmacological assessment of the freezing, antinociception, and exploratory behavior organized in the ventrolateral periaqueductal gray. Pain 2006, 121:94-104.
57. Fernandez Espejo E. Structure of the mouse behavior on the elevated plus-maze test of anxiety. Behav Brain Res 1997, 86:105-112.
58. Rodgers R.J., Lee C., Shepherd J.K. Effects of diazepam on behavioral and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology (Berlin) 1992, 106:102-110.
59. Carrive P., Lee J., Su A. Lidocaine blockade of amygdala output in fear-conditioned rats reduces Fos expression in the ventrolateral periaqueductal gray. Neuroscience 2000, 95:1071-1080.
60. Helmstetter F.J., Tershner S.A., Poore L.H., Belgowan P.S.F. Antinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla. Brain Res 1998, 779:104-118.
61. Ledoux J.E., Farb C., Ruggiero D.A. Topographic organization of neurons in the acoustic thalamus that project to the amygdala. J Neurosci 1990, 10:1043-1054.
62. Oliveira L.C., Nobre M.J., Brandao M.L., Landeira-Fernandez J. Role of amygdala in conditioned and unconditioned fear generated in the periaqueductal gray. Neuroreport 2004, 15:2281-2285.
63. Oliveira M.A., Prado W.A. Role of PAG in the antinociception evoked from the medial or central amygdala in rats. Brain Res Bull 2001, 54:55-63.
64. Brandão M.L., Anseloni V.Z., Pandossio J.E., De Araujo J.E., Castilho V.M. Neurochemical mechanisms of the defensive behavior in the dorsal midbrain. Neurosci Biobehav Rev 1999, 23:863-875.
65. Brandão M.L., Cardoso S.H., Melo L.L., Motta V., Coimbra N.C. Neural substrate of defensive behavior in the midbrain tectum. Neurosci Biobehav Rev 1994, 18:339-346.
66. Baptista D., Bussadori K., Nunes-De-Souza R.L., Canto-De-Souza A. Blockade of fear-induced antinociception with intra-amygdala infusion of midazolam: influence of prior test experience. Brain Res 2009, 1294:29-37.
67. Nunes-De-Souza R.L., Canto-De-Souza A., Da-Costa M., Fornari R.V., Graeff F.G., Pela I.R. Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam. Psychopharmacology (Berlin) 2000, 150:300-310.
68. Brooks J., Tracey I. From nociception to pain perception: imaging the spinal and supraspinal pathways. J Anat 2005, 207:19-33.
69. Redgrave P., Dean P., Souki W., Lewis G. Gnawing and changes in reactivity produced by microinjections of picrotoxin into the superior colliculus of rats. Psychopharmacology 1981, 75:198-203.